Skip to main content
CTOS 2025 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Lu Xie, MD (she/her/hers)

Deputy Medical Director
Peking University People's Hospital
Beijing, Beijing, China (People's Republic)

Lu Xie M.D. Medical and Pediatric Oncologist for Sarcoma；Deputy Medical Director, Musculoskeletal Tumor Center；Clinical Associate Professor, Master supervisor, Peking University. She conducted many trials for target therapy for advaced osteosarcoma, such as apatinib or Apatinib plus
camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial and so on. She would much love to devote herself into the tumor microenviroment for osteosarcoma.

Presentation(s):